View in EDS PDF Full Text

Impacto del incremento en la frecuencia de reuniones del equipo del Programa de Optimización del Uso de Antimicrobianos sobre los indicadores de uso hospitalario de antimicrobianos basados en consumo.

Saved in:
Bibliographic Details
Title: Impacto del incremento en la frecuencia de reuniones del equipo del Programa de Optimización del Uso de Antimicrobianos sobre los indicadores de uso hospitalario de antimicrobianos basados en consumo.
Alternate Title: Impact of increased meeting frequency of the antimicrobial stewardship program team on indicators of the hospital use of antimicrobial agents based on consumption.
Authors: Zas-García, María Inmaculada1 inma_arteixo@hotmail.com, Fernández-Carreira, José Manuel1, González-Fernández, Daniel1, Castelo-Alvárez, Elsa1, Rubio-Sanz, Jesús1, Álvarez-Pérez, Marcos1, Blanco-Suárez, Ana1, Rodríguez-Prida, Jorge1, Rubio-Alfonso, Tania1
Source: Revista Española de Quimioterapia. Oct2025, Vol. 38 Issue 5, p401-411. 11p.
Subjects: ANTIMICROBIAL stewardship, DRUG utilization, ANTI-infective agents, TREATMENT effectiveness, KEY performance indicators (Management), COHORT analysis
Abstract (English): Objectives. To analyze how the increased frequency of meetings held by the Antimicrobial Stewardship Program (PROA) group--during which non-mandatory, supportive prescription audits were conducted--impacted antimicrobial use, using hospital antimicrobial consumption-based indicators. To compare these results with those of other centers of similar complexity. Materials and methods. A retrospective cohort study comparing antimicrobial use through hospital antimicrobial consumption-based indicators in 2023 (the first year the PROA team met twice per week) with 2022 (the last year the PROA team met once per week). The comparison with other centers was carried out using the antimicrobial hospital consumption platform of the Pharmaceutical Care Group for Infectious Diseases of the Spanish Society of Hospital Pharmacy. Results. In 2023 compared to 2022, improvements were observed in 7 out of the 13 indicators: overall consumption of systemic antifungals, carbapenem consumption, metronidazole/piperacillin-tazobactam + carbapenem ratio, fosfomycin consumption, anti-MSSA/anti-MRSA agent ratio, amoxicillin-clavulanate/piperacillin-tazobactam ratio, and fluconazole/echinocandin ratio. In 2023, our hospital ranked above the 50th percentile in 7 out of the 13 indicators. Conclusions. The increased frequency of PROA team meetings may be associated with partial improvements in antimicrobial use, according to hospital antimicrobial consumption-based indicators. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Objetivos. Analizar cómo repercutió en el uso de antimicrobianos el incremento de la periodicidad de las reuniones en que el grupo Programa de Optimización del Uso de Antimicrobianos (PROA) efectuó auditorías no impositivas de ayuda a la prescripción, utilizando los indicadores del uso hospitalario de antimicrobianos basados en consumo. Comparar estos resultados con los de otros centros de similar complejidad. Materiales y métodos. Estudio de cohortes retrospectivo, que comparó el uso de antimicrobianos mediante los indicadores del uso hospitalario de antimicrobianos basados en consumo, en el año 2023 (primer año en que el equipo PROA se reunió dos veces por semana) respecto al 2022 (último año en que el equipo PROA se reunió una vez por semana). La comparación con otros centros se realizó utilizando la plataforma de consumo hospitalario de antimicrobianos del Grupo de Atención Farmacéutica en Enfermedades Infecciosas de la Sociedad Española de Farmacia Hospitalaria. Resultados. En 2023 respecto a 2022 se observaron mejoras en 7 de los 13 indicadores: consumo global de antifúngicos sistémicos, consumo de carbapenémicos, ratio metronidazol/piperacilina-tazobactam + carbapenémicos, consumo de fosfomicina, ratio agentes anti-SASM/anti-SARM, ratio amoxicilina-clavulánico/piperacilina-tazobactam y ratio fluconazol/ equinocandinas. En 2023 nuestro hospital se situó por encima del percentil 50 en 7 de los 13 indicadores. Conclusiones. El aumento de la frecuencia de las reuniones del equipo PROA podría estar asociado a mejoras parciales en el uso de antimicrobianos, según los indicadores del uso hospitalario de antimicrobianos. [ABSTRACT FROM AUTHOR]
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 188129456
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impacto del incremento en la frecuencia de reuniones del equipo del Programa de Optimización del Uso de Antimicrobianos sobre los indicadores de uso hospitalario de antimicrobianos basados en consumo.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Impact of increased meeting frequency of the antimicrobial stewardship program team on indicators of the hospital use of antimicrobial agents based on consumption.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zas-García%2C+María+Inmaculada%22">Zas-García, María Inmaculada</searchLink><relatesTo>1</relatesTo><i> inma_arteixo@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Fernández-Carreira%2C+José+Manuel%22">Fernández-Carreira, José Manuel</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22González-Fernández%2C+Daniel%22">González-Fernández, Daniel</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Castelo-Alvárez%2C+Elsa%22">Castelo-Alvárez, Elsa</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rubio-Sanz%2C+Jesús%22">Rubio-Sanz, Jesús</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Álvarez-Pérez%2C+Marcos%22">Álvarez-Pérez, Marcos</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Blanco-Suárez%2C+Ana%22">Blanco-Suárez, Ana</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rodríguez-Prida%2C+Jorge%22">Rodríguez-Prida, Jorge</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rubio-Alfonso%2C+Tania%22">Rubio-Alfonso, Tania</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revista+Española+de+Quimioterapia%22">Revista Española de Quimioterapia</searchLink>. Oct2025, Vol. 38 Issue 5, p401-411. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22ANTIMICROBIAL+stewardship%22">ANTIMICROBIAL stewardship</searchLink><br /><searchLink fieldCode="DE" term="%22DRUG+utilization%22">DRUG utilization</searchLink><br /><searchLink fieldCode="DE" term="%22ANTI-infective+agents%22">ANTI-infective agents</searchLink><br /><searchLink fieldCode="DE" term="%22TREATMENT+effectiveness%22">TREATMENT effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22KEY+performance+indicators+%28Management%29%22">KEY performance indicators (Management)</searchLink><br /><searchLink fieldCode="DE" term="%22COHORT+analysis%22">COHORT analysis</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Objectives. To analyze how the increased frequency of meetings held by the Antimicrobial Stewardship Program (PROA) group--during which non-mandatory, supportive prescription audits were conducted--impacted antimicrobial use, using hospital antimicrobial consumption-based indicators. To compare these results with those of other centers of similar complexity. Materials and methods. A retrospective cohort study comparing antimicrobial use through hospital antimicrobial consumption-based indicators in 2023 (the first year the PROA team met twice per week) with 2022 (the last year the PROA team met once per week). The comparison with other centers was carried out using the antimicrobial hospital consumption platform of the Pharmaceutical Care Group for Infectious Diseases of the Spanish Society of Hospital Pharmacy. Results. In 2023 compared to 2022, improvements were observed in 7 out of the 13 indicators: overall consumption of systemic antifungals, carbapenem consumption, metronidazole/piperacillin-tazobactam + carbapenem ratio, fosfomycin consumption, anti-MSSA/anti-MRSA agent ratio, amoxicillin-clavulanate/piperacillin-tazobactam ratio, and fluconazole/echinocandin ratio. In 2023, our hospital ranked above the 50th percentile in 7 out of the 13 indicators. Conclusions. The increased frequency of PROA team meetings may be associated with partial improvements in antimicrobial use, according to hospital antimicrobial consumption-based indicators. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Objetivos. Analizar cómo repercutió en el uso de antimicrobianos el incremento de la periodicidad de las reuniones en que el grupo Programa de Optimización del Uso de Antimicrobianos (PROA) efectuó auditorías no impositivas de ayuda a la prescripción, utilizando los indicadores del uso hospitalario de antimicrobianos basados en consumo. Comparar estos resultados con los de otros centros de similar complejidad. Materiales y métodos. Estudio de cohortes retrospectivo, que comparó el uso de antimicrobianos mediante los indicadores del uso hospitalario de antimicrobianos basados en consumo, en el año 2023 (primer año en que el equipo PROA se reunió dos veces por semana) respecto al 2022 (último año en que el equipo PROA se reunió una vez por semana). La comparación con otros centros se realizó utilizando la plataforma de consumo hospitalario de antimicrobianos del Grupo de Atención Farmacéutica en Enfermedades Infecciosas de la Sociedad Española de Farmacia Hospitalaria. Resultados. En 2023 respecto a 2022 se observaron mejoras en 7 de los 13 indicadores: consumo global de antifúngicos sistémicos, consumo de carbapenémicos, ratio metronidazol/piperacilina-tazobactam + carbapenémicos, consumo de fosfomicina, ratio agentes anti-SASM/anti-SARM, ratio amoxicilina-clavulánico/piperacilina-tazobactam y ratio fluconazol/ equinocandinas. En 2023 nuestro hospital se situó por encima del percentil 50 en 7 de los 13 indicadores. Conclusiones. El aumento de la frecuencia de las reuniones del equipo PROA podría estar asociado a mejoras parciales en el uso de antimicrobianos, según los indicadores del uso hospitalario de antimicrobianos. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=188129456
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.37201/req/042.2025
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 401
    Subjects:
      – SubjectFull: ANTIMICROBIAL stewardship
        Type: general
      – SubjectFull: DRUG utilization
        Type: general
      – SubjectFull: ANTI-infective agents
        Type: general
      – SubjectFull: TREATMENT effectiveness
        Type: general
      – SubjectFull: KEY performance indicators (Management)
        Type: general
      – SubjectFull: COHORT analysis
        Type: general
    Titles:
      – TitleFull: Impacto del incremento en la frecuencia de reuniones del equipo del Programa de Optimización del Uso de Antimicrobianos sobre los indicadores de uso hospitalario de antimicrobianos basados en consumo.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zas-García, María Inmaculada
      – PersonEntity:
          Name:
            NameFull: Fernández-Carreira, José Manuel
      – PersonEntity:
          Name:
            NameFull: González-Fernández, Daniel
      – PersonEntity:
          Name:
            NameFull: Castelo-Alvárez, Elsa
      – PersonEntity:
          Name:
            NameFull: Rubio-Sanz, Jesús
      – PersonEntity:
          Name:
            NameFull: Álvarez-Pérez, Marcos
      – PersonEntity:
          Name:
            NameFull: Blanco-Suárez, Ana
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Prida, Jorge
      – PersonEntity:
          Name:
            NameFull: Rubio-Alfonso, Tania
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 02143429
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Revista Española de Quimioterapia
              Type: main
ResultId 1